Program

WEDNESDAY, APRIL 22th, 2015

PRE-MEETING EVENT

13.00-19.00 CINP EDUCATIONAL WORKSHOP: UPDATE ON NEUROPSYCHOPHARMACOLOGY
Brian Leonard (Galway, Ireland) & Gregers Wegener (Aarhus, Denmark) 

THURSDAY, APRIL 23th, 2015

09.00- REGISTRATION OPENS

09.00-10.00 SCNP GENERAL ASSEMBLY (FOR MEMBERS ONLY)

10.00-10.05 PRESIDENT´S WELCOME

10.05-10.50  OPENING LECTURE

Novel pharmacological approaches in the treatment of schizophrenia
Wolfgang Fleishchacker (Innsbruck, Austria)

10.50-11.00 STRECHNING LEGS BREAK

11.00-13.00   SYMPOSIUM

Update on new drugs

Vortioxetine – a novel multimodal antidepressant
Connie Sanchez (New York, USA)

Esketamine Clinical Development Program
Anders Svensson (Sollentuna, Sweden)

Inhalable Loxapine - Real life experience
Tero Hallikainen (Kuopio, Finland)

13.00-13.45  LUNCH 

13.45-15.15  SCNP YOUNG SCIENTIST SYMPOSIUM

Speakers to be announced (based on competition)

15.15-15.45  COFFEE BREAK

15.45-16.30 SCNP LECTURE

The implications of recent research for the way we think about psychosis
Sir Robin Murray (London, United Kingdom)

16.30-17.15  SCNP LECTURE

Should prodromes be treated?
Merete Nordentoft (Copenhagen, Denmark)

17.15-18.45 POSTER SESSION. 
Refreshments

18.45-     SCNP 2015 RECEPTION IN POSTER AND EXHIBITION AREA
Standing dinner with food and wine 

FRIDAY, APRIL 24th, 2015

09.00-09.45  SCNP LECTURE

Societal consequences of (long-term) psychopharmacological treatments
Paul Lichtenstein (Stockholm, Sweden)

09.45-10.15  COFFEE BREAK

10.15-11.45   SYMPOSIUM

Central Effects of Glucagone Like Peptide-1 (GLP-1) Receptor Stimulation

GLP-1: Central and periferal effects of GLP-1 receptor stimulation
Philip Just Larsen (Frankfurt, Germany)

Cocaine addiction - role of GLP-1
Anders Fink-Jensen (Copenhagen, Denmark)

GLP-1 and alcohol abuse
Emil Egecioglu (Gothenburg, Sweden)

11.45-13.15   SYMPOSIUM 

Recent updates on ADHD

Medication for ADHD and criminality and other consequences
Paul Lichtenstein (Stockholm, Sweden)

Mortality in Children, Adolescents and Adults with ADHD - a nationwide cohort study
Søren Dalsgaard (Aarhus, Denmark)

ADHD and substance use - the patient´s perspective
Christina Nehlin Gordh (Uppsala, Sweden)

13.15-14.00  LUNCH 

14.00-14.45 SCNP LECTURE

Metabolic consequences of chronic low grade inflammation in depression
Brian Leodard (Galway, Ireland)

14.45-16.15  SYMPOSIUM

Depression: New options in treatment resistance

The Diagnostic Apathia Scale predicts a dose-remission relationship of home-care T-PEMF in treatment-resistant depression
Erik Roj Larsen (Aarhus, Denmark)

PEMF - a new treatment option
Erik Roj Larsen (Aarhus, Denmark)

Elevtro Convulsive Therapy - an update 
Martin Balslev Jørgensen (Copenhagen, Denmark)

16.15   CONCLUSION OF THE MEETING